> Products > 557-04-0

China 557-04-0 Factory

We rely upon strategic thinking, constant modernisation in all segments, technological advances and of course upon our employees that directly participate inside our success for 557-04-0,CAS NO 557-04-0, By more than 8 years of company, now we have accumulated rich experience and advanced technologies from the generation of our merchandise.
557-04-0, We pursue the management tenet of "Quality is superior, Service is supreme, Reputation is first", and will sincerely create and share success with all clients. We welcome you to contact us for more information and look forward to working with you.

Hot Products

2,3-Difluoroethoxybenzene
Product Name:2,3-Difluoroethoxybenzene
Molecular Formula:C8H8F2O
Molecular Weight:158.15
CAS Registry Number:121219-07-6
benzyl(2S,5R)-5-amino-2-methylpiperidine-1-carboxylate
Product Name:benzyl(2S,5R)-5-amino-2-methylpiperidine-1-carboxylate
Molecular Formula:C14H21ClN2O2
Molecular Weight:284.78
CAS Registry Number:1207853-23-3
7,10-di-Troc-Docetaxel
Product Name:7,10-di-Troc-Docetaxel
Molecular Formula:C49H55Cl6NO18
Molecular Weight:1158.67
CAS Registry Number:114915-14-9
3-Amino-1,2,3,4-tetrahydrocarbazol
Product Name:3-Amino-1,2,3,4-tetrahydrocarbazol
Molecular Formula:C12H14N2
Molecular Weight:186.25
CAS Registry Number:61894-99-3
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline
Product Name:2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline
Molecular Formula:C10H12N4O
Molecular Weight:204.23
CAS Registry Number:1609394-10-6
(4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid
Product Name:(4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid
Molecular Formula:C22H25NO6
Molecular Weight:399.44
CAS Registry Number:196404-55-4 (155396-69-3)

Related Blog
Reviews

Gilteritinib Fumarate
Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!
Bosutinib CAS 380843-75-4
Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
What is an Active Pharmaceutical Ingredient (API in Pharma)?
Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
Prostate Cancer and Darolutamide
Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).
Why API manufacturing companies almostly in China?
In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

Related Search

CAS NO 557-04-0

China 557-04-0 Factory

Related Products

Hot Products

2,3-Difluoroethoxybenzene

benzyl(2S,5R)-5-amino-2-methylpiperidine-1-carboxylate

7,10-di-Troc-Docetaxel

3-Amino-1,2,3,4-tetrahydrocarbazol

2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline

(4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid

Gilteritinib Fumarate

Bosutinib CAS 380843-75-4

What is an Active Pharmaceutical Ingredient (API in Pharma)?

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Prostate Cancer and Darolutamide

Why API manufacturing companies almostly in China?

Lena 2023-07-27 14:27:29

Mike 2022-11-09 09:32:57

Mario 2022-07-28 21:23:03

Christopher Mabey 2023-07-21 06:34:36

Rose 2023-11-12 17:25:17

Hedy 2023-06-14 03:11:51

Related Search

Send Inquiry